Table 1 Characteristics of the N = 907 patients
From: Confirmatory factor analysis of the thyroid-related quality of life questionnaire ThyPRO
Women (%)/men | 787 (87)/120 |
Age (mean (SD)) | 51 (15) |
Diagnosis (n (%)): | |
Diffuse non-toxic goitre | 18 (2) |
Multinodular non-toxic goitre | 154 (17) |
Uninodular non-toxic goitre | 68 (7) |
Solitary cyst | 19 (2) |
Multinodular toxic goitre | 108 (12) |
Uninodular toxic goitre | 37 (4) |
Graves' hyperthyroidism | 168 (19) |
Graves' orbitopathy | 94 (10) |
Autoimmune hypothyroidism | 199 (22) |
Subacute thyroiditis | 9 (1) |
Postpartum thyroiditis | 8 (1) |
Other thyroid disease | 25 (3) |
Months since diagnosis (median (range))* | 27 (–0.9-607) |
Thyroid treatment (n (%)): | |
No thyroid treatment (ever) | 283 (31) |
Antithyroid medication | 162 (18) |
L-Thyroxine | 292 (32) |
Radioiodine | 114 (13) |
Thyroidectomy | 132 (14) |
Other treatment | 4 (0.4) |